CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2021; 08(03): 207-210
DOI: 10.1055/s-0040-1712081
Case Report

Endovascular Coiling in a Patient with Chronic Kidney Disease—A Challenge for Anesthesiologist

Navneh Samagh
1   Department of Anesthesiology, All India Institute of Medical Sciences, Bathinda, Punjab, India
,
Nidhi Singh
2   Department of Anaesthesia and Intensive care, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Kiran Jangra
2   Department of Anaesthesia and Intensive care, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Ajay Kumar
3   Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research, Chandigarh, India
› Author Affiliations

Abstract

A 41-year-old male patient, a known case of autosomal dominant polycystic kidney disease (ADPCKD), presented to our institute with right middle cerebral artery aneurysm for which balloon-assisted endovascular coiling was planned. The major comorbidities were hypertension and end-stage renal disease (ESRD) on hemodialysis, twice weekly. Endovascular coiling was performed under general anesthesia, and special precautions were taken with regard to monitoring, fluid management, use of heparin, and contrast agent. The intraoperative and postoperative course was uneventful, and the patient was discharged after 7 days. In this report, various perioperative challenges of patients with chronic renal failure during coiling are discussed along with the measures to prevent the occurrence of contrast-induced nephropathy.



Publication History

Article published online:
01 June 2020

© 2020. Indian Society of Neuroanaesthesiology and Critical Care. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Cagnazzo F, Gambacciani C, Morganti R, Perrini P. Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review. Acta Neurochir (Wien) 2017; 159 (05) 811-821
  • 2 Craig RG, Hunter JM. Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaesth 2008; 101 (03) 296-310
  • 3 Chen S, Li Q, Wu H, Krafft PR, Wang Z, Zhang JH. The harmful effects of subarachnoid hemorrhage on extracerebral organs. BioMed Res Int 2014; 2014: 858496
  • 4 Rang ST, West NL, Howard J, Cousins J. Anaesthesia for chronic renal disease and renal transplantation. EAU-EBU Update Ser 2006; 4: 246-256
  • 5 Rudnick MR, Goldfarb S, Wexler L. et al Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47 (01) 254-261
  • 6 Katzberg RW, Newhouse JH. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe. ? Radiology 2010; 256 (01) 21-28
  • 7 Mitra R, Rath GP, Dube SK, Hasija N. Anesthetic management in a patient of autosomal dominant polycystic kidney disease with end stage renal disease undergoing endovascular coiling for multiple intracranial aneurysms. J Anaesthesiol Clin Pharmacol 2017; 33 (02) 256-258
  • 8 Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348 (06) 491-499
  • 9 Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J 2014; 65 (02) 96-105
  • 10 Freeman RV, O’Donnell M, Share D. et al Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90 (10) 1068-1073